By Sabela Ojea

Lululemon Athletica on Thursday raised its outlook for the year amid significant sales growth in China. Shares of the athletic-gear maker climbed 13%, to $371.67, in after-hours trading.

Lava Therapeutics on Thursday said a lead candidate aimed at an undisclosed tumor-associated antigen was selected for further development toward clinical studies by Janssen Biotech. Shares of the biotechnology company surged 26%, to $2.40, in after-hours trading.

Tilly's guided for wider-than-expected losses in the fiscal second quarter. Shares of the clothing retailer dropped 13%, to $6.41, in after-hours trading.

Oncorus said it plans to cut nearly its entire workforce and anticipates its finances won't meet its needs beyond the third quarter. Shares of the biotechnology company plunged 24%, to 14 cents, in after-hours trading.

Write to Sabela Ojea at sabela.ojea@wsj.com

(END) Dow Jones Newswires

June 01, 2023 19:23 ET (23:23 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Grafico Azioni LAVA Therapeutics NV (NASDAQ:LVTX)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di LAVA Therapeutics NV
Grafico Azioni LAVA Therapeutics NV (NASDAQ:LVTX)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di LAVA Therapeutics NV